Strategic Foresights
19 Mar
Global AMR Action Plans: WHO, FDA, EMA, and National Policies
Antimicrobial Resistance (AMR) has emerged as one of the most pressing global health threats of the 21st century. Often referred to as the “silent pandemic,” AMR threatens to reverse decades of medical progress, making once-treatable infections potentially deadly. Governments, regulatory bodies, and global health organizations are actively implementing action plans to combat this crisis. This […]
18 Mar
Impact of FDA’s Guidance on Antimicrobial Use in Livestock
Antimicrobial resistance (AMR) is one of the most pressing global public health challenges. The widespread use of antibiotics in livestock and food production systems has contributed to the emergence of resistant bacteria that can spread from animals to humans through food, the environment, and direct contact. To address this risk, global regulatory bodies such as […]
16 Mar
Comparing FDA, EFSA, and WHO Policies on Antimicrobial Use in Food Production
Antimicrobial resistance (AMR) is one of the most pressing global public health challenges. The widespread use of antibiotics in livestock and food production systems has contributed to the emergence of resistant bacteria that can spread from animals to humans through food, the environment, and direct contact. To address this risk, global regulatory bodies such as […]
16 Mar
FDA Approval Pathways for Antimicrobial Drugs
Introduction Antimicrobial resistance (AMR) is one of the most pressing global health challenges. As bacteria evolve to resist existing treatments, the need for new antimicrobial drugs has become critical. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) play a crucial role in ensuring that new antibiotics and antifungal drugs reach patients safely […]
13 Mar
Using Patent Intelligence to Identify Emerging Technology Trends
In today’s innovation-driven economy, organizations must anticipate technological shifts to remain competitive. Patent intelligence has emerged as a powerful strategic tool that enables companies, research institutions, and investors to identify emerging technology trends early. By analyzing global patent data, organizations can uncover innovation patterns, track competitors’ R&D activities, and identify future opportunities. This white paper […]
13 Mar
Biodegradable Materials and the Future of Sustainable Chemistry
Introduction The growing environmental impact of conventional plastics and synthetic materials has intensified the search for sustainable alternatives. Traditional plastics, derived mainly from petrochemical sources, can persist in the environment for hundreds of years, contributing to pollution and ecological damage. In response, biodegradable materials have emerged as a key innovation within sustainable chemistry. These materials […]
23 Feb
Claim Drafting Strategies: How to Balance Scope and Enforceability
🔹 Introduction: Why Claim Drafting Is the Heart of Patent Value A patent’s real power lies in its claims, not just the invention description Overly broad claims risk rejection or invalidation Overly narrow claims limit commercial protection The goal: broad enough to deter competitors, precise enough to withstand examination and enforcement 🔹 1. Understanding Claim […]
19 Feb
Freedom to Operate (FTO) in Pharma: Why Skipping It Can Cost Millions
In pharma, innovation doesn’t fail only in the lab.Many promising products fail at launch because of patent roadblocks that could have been avoided early. This is where Freedom to Operate (FTO) becomes critical. What Is Freedom to Operate (FTO)? Freedom to Operate is a legal and strategic assessment to check whether your product, process, or […]
16 Feb
Service Robots vs Industrial Robots: Which Is Right for Your Business?
🔹 Introduction Robots are no longer limited to factory floors. From hospitals and hotels to warehouses and retail stores, businesses are adopting robots to improve efficiency, reduce costs, and enhance customer experience. However, choosing between service robots and industrial robots can be confusing. This blog breaks down the differences, use cases, benefits, and helps you […]
05 Feb
The Rise of Immune Engagers: Strategic Implications for Pharma R&D and Licensing
The landscape of oncology is undergoing a profound transformation driven by immunotherapy innovation. Over the past decade, immune checkpoint inhibitors, CAR-T therapies, and antibody-drug conjugates have reshaped cancer treatment paradigms. Yet, among these breakthroughs, T cell engagers and related immune engager platforms are emerging as one of the most strategically important innovations in oncology drug […]